934-98-5,With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.934-98-5,2-(4-Methylpiperazin-1-yl)ethanamine,as a common compound, the synthetic route is as follows.
00106] Step 6. To a solution of 4-((lH-indol-3-yl)methyl)-3-ethylaniline (0.8 g, 3.2 mmol) and 4-nitrophenyl carbonochloridate (0.64 g, 3.2 mmol) in THF was added diisopropylethylamine (0.4 g, 3.2 mmol) (16 mL) at 20 ¡ãC and the resulting solution was stirred for 30 min. Then 2-(4-methylpiperazin-l-yl)ethanamine (0.9 g, 6.4 mmol) was added to the solution. After the addition was complete, the mixture was stirred at 20 ¡ãC for 12 h. The mixture was concentrated and purified by preparative HPLC to give l-(4-((lH-indol-3- yl)methyl)-3-ethylphenyl)-3-(2-(4-methylpiperazin-l-yl)ethyl)urea (0.33 g, 26percent) as a yellow solid. 1H NMR (400 MHz, MeOD) delta: 1.13-1.17 (t, 3H), 2.25 (s, 3H), 2.48-2.71 (m, 10H), 3.29- 3.32 (m, 2H), 4.01 (s, 2H), 6.73 (s, 1H), 6.92-6.96 (m, 1H), 7.02-7.08 (m, 3H), 7.18 (s, 1H), 7.29-7.31 (d, J = 8.0 Hz, 1H), 7.39-7.41 (d, J = 7.6 Hz, 1H); MS (M+l+): 220.3.
934-98-5 2-(4-Methylpiperazin-1-yl)ethanamine 70284, apiperazines compound, is more and more widely used in various fields.
Reference£º
Patent; NEUROPORE THERAPIES, INC.; WRASIDLO, Wolfgang; WO2013/148365; (2013); A1;,
Piperazine – Wikipedia
Piperazines – an overview | ScienceDirect Topics